Medical technology giant Becton Dickinson & Co. (NYSE:BDX) is still navigating choppy waters in the 3rd quarter, posting a strong sales but taking a hit its bottom line due, in part, to a $22 million class action lawsuit and continued device tax woes.
becton dickinson
New finance chief at Becton, Dickinson and Co. | Personnel Moves
A new finance chief will take over on Monday at Becton Dickinson & Co. (NYSE:BDX), the company announced this week. BD nabbed Christopher Reidy from his former gig as CFO at ADP Corporation. Reidy has also worked in executive finance roles at NBA Properties Inc. and AT&T.
Partnerships pursue artificial pancreas technology
Two medical technology partnerships are racing to develop artificial pancreas technology that might represent a new chapter in Type I diabetes management.
An artificial pancreas would automate communication between portable, personal glucose monitors and insulin pumps to help manage diabetes without medical supervision.
Becton says former engineer planned to flee to India with trade secrets
An engineer working for Becton Dickinson & Co. (NYSE:BDX) was arrested by the FBI, accused of planning to flee to India with company blueprints for a drug injection device.
Medical device tax: How much are companies paying to government for healthcare reform?
In January 2013, Medical device companies began paying a 2.3% excise tax on U.S. Sales in order to pay for the Patient Protection and Affordable Care Act.
The levy is expected to generate some $30 billion over the next 10 years.
MassDevice.com is tracking the tally paid by several medical device companies, based on quarterly earnings report for the first quarter of 2013. We will update the list as more companies returns file in.
Tallies based on companies with Q1 earnings ended on March 31, 2013
The strange case of the diabetes market
Medical device tax cut about 4% from Q2 earnings growth, Becton Dickinson reports
Healthcare giant Becton Dickinson & Co. (NYSE:BDX) posted some ups and downs for its 2nd quarter of 2013, exceeding analysts’ expectations on earnings but taking some hits with lowered medical device sales and a nearly 4% cut in earnings growth due to the medical device tax.
Becton, Dickinson to add 25 employees to keep up with demand for prefilled syringes
Medical device maker Becton Dickinson & Co. (NYSE:BDX) plans to add 25 additional employees to its Wilson, N.C., where the company plans to manufacture its newly approved prefilled safety syringes.
New CEO takes the helm at Orthofix | Personnel Moves
Becton Dickinson touts closed-doors acquisition of Cato’s pharmacy software solutions
New Jersey healthcare giant Becton Dickinson & Co. (NYSE:BDX) acquired pharmaceutical management systems maker Cato Software Solutions in a closed-doors deal this week.